caribou biosciences is a leading biotechnology company in genome engineering. we develop technology-based solutions for cellular engineering and analysis based on the crispr-cas9 technology platform. cas9, when paired with a guide rna, cuts double-stranded

Caribou Biosciences, Inc. Common Stock

Bought to close all CRBU

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Mike Pelech

Sold short CRBU

Sold all CRBU

Eric Weiner

Aaron Roberts

New position in CRBU

Alex Roznowski

Bought 4900% more CRBU

Bought 50% more CRBU

Sold 50% of CRBU

David

Bought 100% more CRBU

Bought 2% more CRBU

Mahidhar Duvvuru